Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Diabetes Drugs In DPP-4 Inhibitor Class Significantly Increase Risk Of Crohn’s Disease (CD)

February 11, 2019 By Law Offices of Thomas J. Lamb, P.A.

The medical journal Annals of Pharmacotherapy has published an article, “Dipeptidyl Peptidase-4 Inhibitors and Inflammatory Bowel Disease Risk: A Meta-analysis”, which concludes that dipeptidyl peptidase-4 (DPP-4) inhibitors increase the risk of Crohn’s disease (CD). It goes on to point out that these DPP-4 inhibitor diabetes drugs, such as … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Crohn's Disease, dpp-4 drugs, drug side effects, Januvia, Kombiglyze, Onglyza

Certain Diabetes Drugs Like Januvia Associated With Bile Duct Cancer

December 21, 2018 By Law Offices of Thomas J. Lamb, P.A.

The risk of developing bile duct cancer, also known as cholangiocarcinoma, is almost doubled for type 2 diabetics using one of the following diabetes medicines: Januvia (sitagliptin) Janumet (sitagliptin / metformin HCl) Onglyza (saxagliptin) Kombiglyze XR (saxagliptin and metformin) Qtern (dapagliflozin and saxagliptin) Nesina … [Read more...]

Filed Under: Unsafe Drugs Tagged With: bile duct cancer, cholangiocarcinoma, diabetes drugs, dpp-4 drugs, Glyxambi, Janumet, Januvia, Jentadueto, Kazano, Kombiglyze XR, Nesina, Onglyza, Oseni, Qtern, Tradjenta

Current Number Of Lawsuits Filed In The Four Diabetes Drugs Federal Court MDL Cases

February 23, 2018 By Law Offices of Thomas J. Lamb, P.A.

From the February 15, 2018 version of this document, “MDL Statistics Report – Distribution of Pending MDL Dockets by Actions Pending” (accessed 2/21/18), published by the United States Judicial Panel on Multidistrict Litigation (JPML), we get the current number of cases filed in each of the four federal court Multidistrict Litigation (MDL) cases … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Byetta, Diabetic Ketoacidosis (DKA), Farxiga, Foot Amputation, Heart Failure, Invokamet, Invokana, Janumet, Januvia, Kombiglyze, Leg Amputation, Onglyza, Pancreatic Cancer, Toes Amputation, Victoza

Pancreatic Cancer Lawsuits Reinstated for Incretin-Based Diabetes Drugs

January 2, 2018 By Law Offices of Thomas J. Lamb, P.A.

Background Among the several different types of therapies indicated for treating type 2 diabetes are increatin mimetics.  The medications approved by the FDA that fall into this class of drugs are: Byetta (exenatide) Bydureon (exenatide) Januvia (sitagliptin) Janumet (sitagliptin) Victoza (liraglutide) Previous scientific … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Bydureon, Byetta, drug injury lawsuits, increatin mimetics, incretin-based diabetes drugs, Janumet, Januvia, new trials incretin therapy diabetes drugs, Pancreatic Cancer, side effects, Victoza

Rhabdomyolysis May Be Linked To A New Class Of Oral Diabetes Medicines

October 16, 2017 By Law Offices of Thomas J. Lamb, P.A.

A class of diabetes drugs referred to as dipeptidyl peptidase-4 inhibitors may be associated with rhabdomyolysis, a side effect which involves severe muscle damage. In more detail, rhabdomyolysis is the breakdown of muscle tissue that leads to the release of muscle fiber contents into the blood. These substances are harmful to the kidney and … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Glyxambi, Janumet, Januvia, Jentadueto, Kazano, Kombiglyze, Nesina, Onglyza, Oseni, Qtern, Rhabdomyolysis, Tradjenta

Type 2 Diabetes Drugs Linked to Severe Joint Pain

June 2, 2017 By Law Offices of Thomas J. Lamb, P.A.

Health Canada recently warned about the risk of severe, debilitating joint pain as a result of taking type 2 diabetes medications called dipeptidylpeptidase-4 (DPP-4) inhibitors. This DPP-4 inhibitors class of drugs includes the following: Onglyza Kombiglyze XR Nesina Kazano Oseni Glyxambi Janumet (XR) Januvia … [Read more...]

Filed Under: Unsafe Drugs Tagged With: diabetes drugs joint pain, diabetes drugs side effects, dipeptidylpeptidase-4 inhibitors, dpp-4 drugs, drugs side effects, Glyxambi, Janumet (XR), Januvia, Jentadueto, joint pain causes, Kazano, Kombiglyze XR, Nesina, Onglyza, Oseni, Qtern, Tradjenta, type 2 diabetes drugs

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.